Invenomic Fund Investor Class shares (BIVRX)

NASDAQ · Mutual Fund · Delayed Price · Currency is USD
16.45
+0.06 (0.37%)
Apr 17, 2025, 4:00 PM EDT
-10.26%
Fund Assets 1.40B
Expense Ratio 3.42%
Min. Investment $5,000
Turnover n/a
Dividend (ttm) 0.60
Dividend Yield 3.62%
Dividend Growth -84.62%
Payout Frequency Annual
Ex-Dividend Date Dec 16, 2024
Previous Close 16.39
YTD Return -3.01%
1-Year Return -6.97%
5-Year Return 175.41%
52-Week Low n/a
52-Week High n/a
Beta (5Y) n/a
Holdings 317
Inception Date Jun 19, 2017

About BIVRX

The Invenomic Fund Investor Class shares (BIVRX) seeks to be fully invested in the long portfolio, while allowing the size of the short portfolio to fluctuate based on the market opportunity.

Category Long-Short Equity
Performance Rating High
Risk Rating Above Average
Stock Exchange NASDAQ
Ticker Symbol BIVRX
Share Class Investor Class Shares
Index S&P Composite 1500 TR

Performance

BIVRX had a total return of -6.97% in the past year, including dividends. Since the fund's inception, the average annual return has been 15.46%.

Other Share Classes

These are alternative share classes of the same fund, from the same provider.

Symbol Share Class Expense Ratio
BIVSX Super Institutional Class Shares 2.92%
BIVIX Institutional Class Shares 3.17%

Top 10 Holdings

26.65% of assets
Name Symbol Weight
First American Government Obligations Fund FGXXX 6.76%
Match Group, Inc. MTCH 2.80%
Global Payments Inc. GPN 2.59%
Sonoco Products Company SON 2.56%
Lyft, Inc. LYFT 2.40%
DENTSPLY SIRONA Inc. XRAY 2.08%
Chord Energy Corporation CHRD 1.98%
Dun & Bradstreet Holdings, Inc. DNB 1.93%
Clarivate Plc CLVT 1.81%
Verizon Communications Inc. VZ 1.73%
View More Holdings

Dividend History

Ex-Dividend Amount Pay Date
Dec 16, 2024 $0.602 Dec 17, 2024
Dec 13, 2023 $3.9134 Dec 14, 2023
Dec 14, 2022 $5.6885 Dec 15, 2022
Dec 15, 2021 $2.504 Dec 16, 2021
Dec 16, 2020 $0.3831 Dec 16, 2020
Dec 16, 2019 $0.3664 Dec 16, 2019
Full Dividend History